Other World Class Magnetic Resonance Research in France Also Enabled by Novel Bruker Systems PARIS, France – Bruker announced today that it has successfully installed its BioSpec® 170/25 system at the CEA NeuroSpin research center near Paris, France. The world’s first horizontal ultra-high magnetic field 17.2 Tesla MRI system features a magnet bore diameter of […]
New Toolkit Provides Co-Registration of 3D Optical Images with Other Imaging Modalities to Better Understand Disease Progression and Therapeutic Response HOPKINTON, Mass. – Caliper Life Sciences, Inc. (NASDAQ: CALP), a leading provider of tools and services for drug discovery, life sciences research and molecular diagnostics, today introduced software and accessory items to enable the direct […]
KYOTO, JAPAN, Reinforcing its commitment to researchers and clinicians, GE Healthcare, a unit of General Electric Company (NYSE:GE) is showcasing a comprehensive molecular imaging portfolio—encompassing tracer development, pre-clinical imaging and highly advanced imaging equipment— to provide insight into the origins of disease, at the World Molecular Imaging Congress (WMIC), Booth #212, September 8 through 11 […]
Kyoto, Japan – Aspect Magnet Technologies and Mediso Medical Imaging Systems announced today at the World Molecular Imaging Congress (https://www.wmicmeeting.org/dev/) (WMIC) that the companies have begun a collaboration to develop a multi modality system that combines the benefits of positron emission tomography (PET) and magnetic resonance imaging (MRI (https://aspect-mr.com/page.asp?page_id=42)). The two modalities will be integrated […]
WALTHAM, Massachusetts – PerkinElmer, Inc. (NYSE: PKI), a global leader focused on the health and safety of people and the environment, today announced that it has acquired VisEn Medical, Inc., an in vivo molecular imaging technology company based in Bedford, Massachusetts. The acquisition enables PerkinElmer to enhance its cellular imaging business, by expanding the Company’s […]
BOTHELL, WA – SonoSite, Inc. (NASDAQ: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that on June 30, 2010, it completed its acquisition of privately held VisualSonics, a Toronto-based company focused on ultra high-frequency micro-ultrasound technology, for $67.9 million net of cash and debt. “This acquisition positions SonoSite for long-term […]
New position reflects CRi’s continued growth in 2010. Woburn, Massachusetts – Cambridge Research & Instrumentation, Inc. (CRi), a leader in pre-clinical and molecular imaging, today announced the appointment of Darren Lee as the company’s vice president of marketing. He will be responsible for leading all strategic marketing activities for the company’s products and sales across […]
Offering researchers an unrivaled range of preclinical contrast agents for small animal in vivo imaging. Bergisch Gladbach, Germany, and Berlin, Germany — Viscover marks the result of a fruitful collaboration between Miltenyi Biotec GmbH and nanoPET Pharma GmbH. Within this strategic alliance, Miltenyi Biotec is responsible for the distribution of Viscover products developed and manufactured […]
Technology Leader in Ultra High-Frequency Micro-Ultrasound, VisualSonics, Generated $30M in Trailing Twelve Month Revenues and $5M of EBITDAS. Company is a Leader in the $350M Pre-Clinical Imaging Research Market Acquisition Stages Move of Ultra High-Frequency Ultrasound into Clinical Medicine BOTHELL, WA — SonoSite, Inc. (NASDAQ: SONO), the world leader and specialist in bedside and point-of-care […]
New Agents Further Extend VisEn’s Leading Fluorescence Molecular Imaging Agent Portfolio to Enable Expanded Readouts of Key Biomarkers in Research and Drug Development BEDFORD, Mass. and WARSAW, Poland — — VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced the commercial launch of two new imaging agents — ProSense® […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
